(Q38171455)

30 August 2017

title

Switching of EBV cycles between latent and lytic states (English)

1 reference

latency-replication decision

30 August 2017

main subject

1 reference

Gene Ontology release 2020-05-02

Takayuki Murata

1

1 reference

30 August 2017

Tatsuya Tsurumi

series ordinal

2

1 reference

30 August 2017

language of work or name

1 reference

11 December 2013

1 reference

Reviews in Medical Virology

30 August 2017

published in

1 reference

30 August 2017

volume

24

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

142-153

1 reference

Epstein-Barr virus and oncogenesis: from latent genes to tumours

30 August 2017

cites work

1 reference

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

Latent and lytic Epstein-Barr virus replication strategies

21 January 2018

1 reference

Reactivation of Epstein-Barr virus from latency

21 January 2018

1 reference

Replication of Epstein-Barr viral DNA.

21 January 2018

1 reference

Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells

21 January 2018

1 reference

Host-tumor interactions in nasopharyngeal carcinomas

21 January 2018

1 reference

Epstein-Barr virus-encoded BARF1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation

21 January 2018

1 reference

An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection

21 January 2018

1 reference

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

21 January 2018

1 reference

Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas

21 January 2018

1 reference

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes

21 January 2018

1 reference

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome

21 January 2018

1 reference

Lytic cycle switches of oncogenic human gammaherpesviruses

21 January 2018

1 reference

Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

21 January 2018

1 reference

bZIP proteins of human gammaherpesviruses.

21 January 2018

1 reference

Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays

21 January 2018

1 reference

The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus

21 January 2018

1 reference

The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction

21 January 2018

1 reference

Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.

21 January 2018

1 reference

The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.

21 January 2018

1 reference

Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites

21 January 2018

1 reference

Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases

21 January 2018

1 reference

Regulation of Epstein-Barr virus latency by latent membrane protein 2.

21 January 2018

1 reference

Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member

21 January 2018

1 reference

Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter

21 January 2018

1 reference

Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency

21 January 2018

1 reference

Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation

21 January 2018

1 reference

Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.

21 January 2018

1 reference

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

21 January 2018

1 reference

Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter

21 January 2018

1 reference

Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency

21 January 2018

1 reference

Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway

21 January 2018

1 reference

Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins

21 January 2018

1 reference

Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

21 January 2018

1 reference

Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle

21 January 2018

1 reference

Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines

21 January 2018

1 reference

Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation

21 January 2018

1 reference

Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation

21 January 2018

1 reference

The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivation

21 January 2018

1 reference

Enhancement of Zta-activated lytic transcription of Epstein-Barr virus by Ku80.

21 January 2018

1 reference

TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein

21 January 2018

1 reference

Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus

21 January 2018

1 reference

ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus

21 January 2018

1 reference

ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus

21 January 2018

1 reference

Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner

21 January 2018

1 reference

Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency

21 January 2018

1 reference

The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency

21 January 2018

1 reference

Smubp-2 represses the Epstein-Barr virus lytic switch promoter

21 January 2018

1 reference

The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency

21 January 2018

1 reference

Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation

21 January 2018

1 reference

Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines

21 January 2018

1 reference

Nitric oxide (NO): an effector of apoptosis

21 January 2018

1 reference

Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase

21 January 2018

1 reference

Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha

21 January 2018

1 reference

Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection

21 January 2018

1 reference

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

21 January 2018

1 reference

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1

21 January 2018

1 reference

The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

21 January 2018

1 reference

NF-kappaB inhibits gammaherpesvirus lytic replication

21 January 2018

1 reference

NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells

21 January 2018

1 reference

Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

21 January 2018

1 reference

Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr Virus infected B cells

21 January 2018

1 reference

Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors

21 January 2018

1 reference

Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors

21 January 2018

1 reference

A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

21 January 2018

1 reference

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

21 January 2018

1 reference

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

21 January 2018

1 reference

Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression

21 January 2018

1 reference

LMP1 structure and signal transduction

21 January 2018

1 reference

The significance of LMP1 expression in nasopharyngeal carcinoma

21 January 2018

1 reference

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

21 January 2018

1 reference

Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma.

21 January 2018

1 reference

12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase

21 January 2018

1 reference

Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus

21 January 2018

1 reference

Roles of cell signaling pathways in cell-to-cell contact-mediated Epstein-Barr virus transmission

21 January 2018

1 reference

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

21 January 2018

1 reference

BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression

21 January 2018

1 reference

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells

21 January 2018

1 reference

Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors

21 January 2018

1 reference

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency

21 January 2018

1 reference

Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome

21 January 2018

1 reference

The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

21 January 2018

1 reference

Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters

21 January 2018

1 reference

Proteins of purified Epstein-Barr virus

21 January 2018

1 reference

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes

21 January 2018

1 reference

Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification

21 January 2018

1 reference

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression

21 January 2018

1 reference

Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.

21 January 2018

1 reference

Genome guardian p53 and viral infections

21 January 2018

1 reference

Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication.

21 January 2018

1 reference

Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex

21 January 2018

1 reference

Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.

21 January 2018

1 reference

Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication

21 January 2018

1 reference

Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells

21 January 2018

1 reference

Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment.

21 January 2018

1 reference

Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments

21 January 2018

1 reference

Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments

21 January 2018

1 reference

DNA-damage response pathways triggered by viral replication.

21 January 2018

1 reference

Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.

21 January 2018

1 reference

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

21 January 2018

1 reference

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.1780

1 reference

30 August 2017

1 reference